A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07732400 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Dysfunction-associated Steatohepatitis (MASH)

Interventions

GENETIC: VV-14303

Sponsor

Kriya Therapeutics, Inc.